DOPAR

Welcome to the Brand page for “DOPAR”, which is offered here for Prescription pharmaceutical preparation containing l(-) b-(3,4-dihydroxyphenyl)-alanine for use in the treatment of neurologic disorders;.

Its status is currently believed to be active. Its class is unavailable. “DOPAR” is believed to be currently owned by “NORWICH EATON PHARMACEUTICALS, INC.”


Owner:
NORWICH EATON PHARMACEUTICALS, INC.
Owner Details
Description:
PRESCRIPTION PHARMACEUTICAL PREPARATION CONTAINING L(-) B-(3,4-DIHYDROXYPHENYL)-ALANINE FOR USE IN THE TREATMENT OF NEUROLOGIC DISORDERS;
Categories: PRESCRIPTION PHARMACEUTICAL PREPARATION CONTAINING L